|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||3.7600 - 3.7600|
|52 Week Range||3.1500 - 4.2400|
|Beta (5Y Monthly)||0.88|
|PE Ratio (TTM)||12.53|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Dec 20, 2019|
|1y Target Est||N/A|
SetBone Medical Ltd., a company that has developed a novel bone cement for the treatment of spinal vertebrae fractures and other orthopedic procedures, announced today that it has closed an oversubscribed investment round of $1.6 million. Investors in the round include The Trendlines Group (SGX: 42T) (OTCQX: TRNLY); Agriline, a trust of which Vincent Tchenguiz is a discretionary beneficiary; Chicago ArchAngels; and other private investors. The funds raised will support the next stage of developm
Severe heart failure is the most life-threatening medical condition in all age groups across the globe. Implantable heart pumps, known as Ventricular Assist Devices (or VADs), have proven to sustainably increase long term survival. However, due to the need for tethering to an external power source using a cable exiting the body through the abdomen, these devices have not yet been fully accepted as mainstream therapy.
The Trendlines Group Ltd. ("Trendlines") , is pleased to announce that its fund, The Trendlines Agrifood Fund Pte. Ltd., has invested in AgriG8 Pte Ltd. ("AgriG8") as its first foray into the thriving agri-fintech space.